Skip to content
Running a Study
1 Minute Read

Make Virtual Monitoring Work for You: How eSource Can Help Sponsors Monitor Virtually During Covid-19

Striving for site success and business continuity amidst our global pandemic? Virtual monitoring bypasses the need for travel, made nearly impossible with the coronavirus, and becomes a critical technological solution for the kind of business continuity that keeps the industry reliable and strong. You can turn complexity into meaningful change.

In this webinar, Raymond Nomizu, co-founder and CEO of Clinical Research IO, and Gail Hinkson, CEO of Pinnacle Clinical Research and vice president at Summit Clinical Research, discuss the rise of site-based eSource technologies. Examine a case study where a site-based eSource solution was employed on a multi-site trial, sharing how sites can:

  • Earn significant benefits by using eSource for remote monitoring
  • Leverage the growing use of site-centric eSource technology among research sites
  • Measure cost savings and quantify benefits with real-time data access

 

CRIO favicon by Team CRIO
Share this post
You may also find interesting
Explore our Blog
Article on electronic health records recently published in JSCDM
CRIO Company News
1 Minute Read -

JSCDM: Comparison of electronic health records and electronic source data in clinical research trials

The Journal of the Society for Clinical Data Management (JSCDM) recently published the original research article “Comparison of electronic health records and electronic source data in clinical research trials: a retrospective review” which was co-authored by Amelia Tian, CRIO Solutions Consultant, and Olivia Dennis, CRIO Analytics and Data Migration Manager, alongside Dr. Elena Christofides (Endocrinology...

21 cfr compliance update
Running a Site
5 Minute Read -

21 CFR Part 11 Regulation Compliance Update

Compliance Update:  The 21 CFR Part 11 Regulation is a cornerstone of conducting clinical trials in today’s world.  The release of the regulation 1997 established guidelines for the use of electronic records and electronic signatures in FDA-regulated industries and had a significant impact on the pharmaceutical and medical device industries. The FDA began working on...

Get articles delivered to your inbox, every week